AKÇORA YILDIZ, D. Et Al. 2024. Inhibition of O6-methylguanine-DNA-methyltransferase (MGMT) by lomeguatrib reduces multiple myeloma cell viability and impairs DNA repair in MGMT-proficient cells. CHEMICAL BIOLOGY & DRUG DESIGN , no.2 .

AKÇORA YILDIZ, D., ÖZKAN, T., ÇETİNTAV, B., Yukselten, Y., Calis, S., Sevim-Nalkiran, H., ... Turkel, N.(2024). Inhibition of O6-methylguanine-DNA-methyltransferase (MGMT) by lomeguatrib reduces multiple myeloma cell viability and impairs DNA repair in MGMT-proficient cells. CHEMICAL BIOLOGY & DRUG DESIGN , no.2.

AKÇORA YILDIZ, DİLARA Et Al. "Inhibition of O6-methylguanine-DNA-methyltransferase (MGMT) by lomeguatrib reduces multiple myeloma cell viability and impairs DNA repair in MGMT-proficient cells," CHEMICAL BIOLOGY & DRUG DESIGN , no.2, 2024

AKÇORA YILDIZ, DİLARA A. Et Al. "Inhibition of O6-methylguanine-DNA-methyltransferase (MGMT) by lomeguatrib reduces multiple myeloma cell viability and impairs DNA repair in MGMT-proficient cells." CHEMICAL BIOLOGY & DRUG DESIGN , no.2, 2024

AKÇORA YILDIZ, D. Et Al. (2024) . "Inhibition of O6-methylguanine-DNA-methyltransferase (MGMT) by lomeguatrib reduces multiple myeloma cell viability and impairs DNA repair in MGMT-proficient cells." CHEMICAL BIOLOGY & DRUG DESIGN , no.2.

@article{article, author={DİLARA AKÇORA YILDIZ Et Al. }, title={Inhibition of O6-methylguanine-DNA-methyltransferase (MGMT) by lomeguatrib reduces multiple myeloma cell viability and impairs DNA repair in MGMT-proficient cells}, journal={CHEMICAL BIOLOGY & DRUG DESIGN}, year=2024}